Scarica l'app Stockscreener
4.67
4.01%
0.18
Dopo l'orario di chiusura:
4.62
-0.05
-1.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.49
Aprire:
$4.48
Volume 24 ore:
230.61K
Relative Volume:
0.37
Capitalizzazione di mercato:
$299.16M
Reddito:
-
Utile/perdita netta:
$-45.08M
Rapporto P/E:
-6.3973
EPS:
-0.73
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
+9.88%
1M Prestazione:
+30.08%
6M Prestazione:
+193.71%
1 anno Prestazione:
+90.61%
Intervallo 1D:
$4.41
$4.70
Intervallo di 1 settimana:
$4.13
$4.70
Portata 52W:
$0.726
$4.70
Galectin Therapeutics Inc Stock (GALT) Company Profile
Nome
Galectin Therapeutics Inc
Settore
Industria
Telefono
678-620-3186
Indirizzo
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Confronta GALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
4.67 | 283.15M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-13 | Iniziato | B. Riley FBR | Buy |
| 2017-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-19 | Iniziato | ROTH Capital | Buy |
| 2017-03-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Downgrade | ROTH Capital | Buy → Sell |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-09-21 | Iniziato | H.C. Wainwright | Buy |
| 2014-08-01 | Downgrade | Aegis Capital | Buy → Hold |
| 2014-07-30 | Reiterato | MLV & Co | Buy |
| 2014-07-29 | Reiterato | MLV & Co | Buy |
| 2014-04-02 | Reiterato | MLV & Co | Buy |
| 2014-02-10 | Reiterato | Aegis Capital | Buy |
| 2014-01-09 | Reiterato | Aegis Capital | Buy |
| 2013-12-03 | Iniziato | MLV & Co | Buy |
| 2013-08-19 | Reiterato | Aegis Capital | Buy |
Mostra tutto
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
Analyzing recovery setups for Galectin Therapeutics Inc. investorsWeekly Risk Report & Safe Entry Momentum Tips - Newser
Galectin Therapeutics Inc. stock chart pattern explainedQuarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Can swing trading help recover from Galectin Therapeutics Inc. lossesWeekly Volume Report & Weekly Chart Analysis and Guides - Newser
Can a trend reversal in Galectin Therapeutics Inc. lead to recovery2025 Valuation Update & Advanced Technical Analysis Signals - Newser
Should you wait for a breakout in Galectin Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - Newser
Custom watchlist performance reports with Galectin Therapeutics Inc.Market Movers & AI Based Trade Execution Alerts - Newser
Is now a turning point for Galectin Therapeutics Inc.Chart Signals & Smart Money Movement Tracker - Newser
What does recent volatility data suggest for Galectin Therapeutics Inc.Weekly Trade Report & Community Consensus Picks - Newser
What indicators show strength in Galectin Therapeutics Inc.Earnings Performance Report & Reliable Breakout Forecasts - Newser
How to monitor Galectin Therapeutics Inc. with trend dashboards2025 Investor Takeaways & Daily Price Action Insights - Newser
Chart based analysis of Galectin Therapeutics Inc. trendsWeekly Investment Recap & Community Verified Trade Alerts - Newser
Will Galectin Therapeutics Inc. benefit from macro trendsPortfolio Return Report & Real-Time Buy Zone Alerts - Newser
Volume spikes in Galectin Therapeutics Inc. stock – what they mean2025 Trade Ideas & Weekly Momentum Picks - Newser
Why Galectin Therapeutics Inc. is moving todayWeekly Profit Report & Fast Moving Stock Watchlists - Newser
What does recent volatility data suggest for Galectin Therapeutics IncEarnings Growth Summary & Safe Capital Growth Plans - Newser
Applying chart zones and confluence areas to Galectin Therapeutics Inc.2025 Technical Patterns & Safe Capital Growth Trade Ideas - Newser
What is the dividend yield of Galectin Therapeutics Inc.2025 Price Momentum & Daily Stock Trend Watchlist - khodrobank.com
Will Galectin Therapeutics Inc. stock recover after recent dropJuly 2025 Earnings & Trade Opportunity Analysis Reports - Newser
can a trend reversal in galectin therapeutics inc. lead to recoveryMarket Sentiment Summary & Reliable Price Action Trade Plans - Newser
Is Galectin Therapeutics Inc. a speculative investmentMarket Trend Report & Weekly Chart Analysis and Guides - khodrobank.com
Price action breakdown for Galectin Therapeutics Inc.Trade Volume Summary & High Accuracy Trade Signal Alerts - Newser
What is the earnings history of Galectin Therapeutics Inc.July 2025 Retail & Fast Gain Stock Trading Tips - khodrobank.com
Does Galectin Therapeutics Inc. have consistent dividend growth2025 Market WrapUp & Real-Time Buy Signal Alerts - khodrobank.com
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
What’s the outlook for Galectin Therapeutics Inc.’s sectorGap Down & Accurate Technical Buy Alerts - khodrobank.com
Biotech Leader Galectin Therapeutics Takes Stage at H.C. Wainwright Global Investment Conference in NYC - Stock Titan
Can Galectin Therapeutics Inc. navigate macro headwindsWeekly Stock Report & Growth Oriented Trade Recommendations - khodrobank.com
Chart based exit strategy for Galectin Therapeutics Inc.July 2025 Outlook & Weekly Top Gainers Alerts - Newser
Tools to monitor Galectin Therapeutics Inc. recovery probabilityJuly 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
How moving averages guide Galectin Therapeutics Inc. tradingWatch List & Daily Market Momentum Tracking - Newser
A | Does Galectin Therapeutics Inc. have a competitive edgeJuly 2025 Opening Moves & Verified Momentum Stock Ideas - khodrobank.com
How cyclical is Galectin Therapeutics Inc.’s revenue streamWeekly Trade Review & Precise Trade Entry Recommendations - khodrobank.com
Does Galectin Therapeutics Inc. have pricing powerWeekly Trade Report & Community Verified Trade Signals - khodrobank.com
Will Galectin Therapeutics Inc. face regulatory challenges2025 Short Interest & Stepwise Entry and Exit Trade Signals - khodrobank.com
Is Galectin Therapeutics Inc. trending in predictive chart models2025 Top Decliners & Daily Profit Focused Stock Screening - Newser
Does Galectin Therapeutics Inc. show high probability of reboundMarket Activity Summary & Breakout Confirmation Alerts - Newser
Galectin Therapeutics Inc. stock trend outlook and recovery pathEarnings Beat & Free Weekly Watchlist of Top Performers - Newser
What MACD and RSI say about Galectin Therapeutics Inc.Portfolio Performance Summary & Stepwise Swing Trade Plans - Newser
Using Bollinger Bands to evaluate Galectin Therapeutics Inc.Quarterly Portfolio Report & Safe Investment Capital Preservation Plans - Newser
Using data models to predict Galectin Therapeutics Inc. stock movementMarket Growth Summary & Short-Term Trading Opportunity Alerts - Newser
Relative strength of Galectin Therapeutics Inc. in sector analysisBull Run & Entry Point Confirmation Alerts - Newser
Will Galectin Therapeutics Inc. see short term momentumMarket Rally & Daily Stock Trend Watchlist - Newser
Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Galectin Therapeutics Inc Azioni (GALT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FREEMAN KEVIN D | Director |
Jul 17 '25 |
Buy |
2.90 |
5,000 |
14,495 |
49,769 |
| CZIRR JAMES C | 10% Owner |
Jun 06 '25 |
Option Exercise |
2.16 |
323,125 |
699,344 |
1,045,541 |
| Shlevin Harold H. | Director |
Dec 30 '24 |
Buy |
1.16 |
6,500 |
7,540 |
15,206 |
| Jamil Khurram | Chief Medical Officer |
Dec 23 '24 |
Option Exercise |
0.00 |
40,000 |
0 |
40,000 |
| Jamil Khurram | Chief Medical Officer |
Dec 23 '24 |
Sale |
0.88 |
13,654 |
12,044 |
26,346 |
| LEWIS JOEL | President and CEO |
Dec 23 '24 |
Option Exercise |
0.00 |
56,000 |
0 |
953,012 |
| LEWIS JOEL | President and CEO |
Dec 23 '24 |
Sale |
0.89 |
56,000 |
49,610 |
897,012 |
| CALLICUTT JACK W | Chief Financial Officer |
Dec 23 '24 |
Option Exercise |
0.00 |
40,000 |
0 |
47,614 |
| CALLICUTT JACK W | Chief Financial Officer |
Dec 23 '24 |
Sale |
0.89 |
40,000 |
35,492 |
7,614 |
| Zordani Richard A. Jr. | Director |
Dec 24 '24 |
Buy |
0.82 |
10,000 |
8,164 |
42,083 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):